0001415889-24-002121.txt : 20240131
0001415889-24-002121.hdr.sgml : 20240131
20240131205357
ACCESSION NUMBER: 0001415889-24-002121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosett Max
CENTRAL INDEX KEY: 0001994071
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 24584702
MAIL ADDRESS:
STREET 1: C/O MORPHIMMUNE INC.
STREET 2: 101 FOUNDRY DRIVE, SUITE 1200
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
form4-02012024_010250.xml
X0508
4
2024-01-31
0001472012
Immunome Inc.
IMNM
0001994071
Rosett Max
C/O IMMUNOME, INC.
665 STOCKTON DRIVE, SUITE 300
EXTON
PA
19341
false
true
false
false
EVP, OPERATIONS & INTERIM CFO
0
Stock option (right to buy)
16.57
2024-01-31
4
A
0
175000
0
A
2034-01-30
Common Stock
175000
175000
D
25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
/s/ Sandra Stoneman, Attorney-in-Fact
2024-01-31